Concepedia

Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes

Bradford S. Hamilton, Frank Himmelsbach, Herbert Nar, Annette Schuler‐Metz, Paula M. Krosky, Joan Guo, Rong Guo, Shi Meng, Yi Zhao, Deepak S. Lala,

European Journal of Pharmacology · 2014 · 29 citations · 21 references

DOI

Concepts

References

21

A Transgenic Model of Visceral Obesity and the Metabolic Syndrome

Hiroaki Masuzaki, J. Paterson, Hiroshi Shinyama et al. · Science · 2001 · 1.8K citations

, , +17

MINERALOCORTICOID ACTIVITY OF LIQUORICE: 11-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY COMES OF AGE

P Stewart, Rossella Valentino, Andrew Wallace et al. · The Lancet · 1987 · 806 citations

, , +6

Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

Ralph A. DeFronzo, Devjit Tripathy, Dawn C. Schwenke et al. · New England Journal of Medicine · 2011 · 743 citations · Full text

, , +14

Novel Adipose Tissue–Mediated Resistance to Diet-Induced Visceral Obesity in 11β-Hydroxysteroid Dehydrogenase Type 1–Deficient Mice

Nicholas M. Morton, Janice M. Paterson, Hiroaki Masuzaki et al. · Diabetes · 2004 · 504 citations · Full text

, , +17

11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

Anne Hermanowski‐Vosatka, James M. Balkovec, Kang Cheng et al. · The Journal of Experimental Medicine · 2005 · 363 citations · Full text

, , +17